Taipei, Taiwan

Chiu-Nai Lin

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiu-Nai Lin. Retrieved from https://idiyas.com/inventor/chiu-nai-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Chiu-Nai Lin in T Cell Lymphoma Treatment

Introduction: Chiu-Nai Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of T cell lymphomas. His innovative approach combines traditional Chinese medicine with modern therapeutic techniques.

Latest Patents: Chiu-Nai Lin holds a patent for a method of treating T cell lymphomas. The patent describes a method that involves administering a Chinese medicine composition to a subject in need. This composition is derived from an extract of a specific mixture, showcasing the integration of traditional practices into contemporary medical treatments. He has 1 patent to his name.

Career Highlights: Throughout his career, Chiu-Nai Lin has focused on developing effective treatment methods for complex medical conditions. His work emphasizes the importance of alternative medicine and its potential benefits in modern healthcare.

Collaborations: Chiu-Nai Lin has collaborated with notable colleagues in his field, including Hsuan-Ching Tseng and Chin-Chuan Lo. These partnerships have contributed to the advancement of his research and the development of innovative treatment methods.

Conclusion: Chiu-Nai Lin's contributions to the treatment of T cell lymphomas highlight the potential of integrating traditional medicine with modern science. His innovative methods pave the way for new therapeutic options in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…